Peptides
What are peptides? how they work in the body
Here is what actually matters. Your body produces thousands of peptides naturally. They act as signaling molecules: hormones, neurotransmitters, growth factors, immune modulators. Insulin is a peptide hormone. So is oxytocin. So are the endorphins that flood your system after a hard workout. When your gut releases GLP-1 after a meal to signal satiety to your brain, that is a peptide doing
its job.
What makes peptides different from proteins is size. Proteins are generally longer than 50 amino acids and fold into complex three-dimensional structures. Peptides are shorter, simpler, and act more like targeted chemical messages than structural building blocks.
What makes peptides different from steroids is mechanism. Anabolic steroids are synthetic versions of testosterone that bind nuclear receptors and directly alter gene transcription. They are a blunt instrument: systemic, powerful, and loaded with side effects from acne to liver damage to cardiovascular strain. Peptides work through cell-surface receptor binding and downstream signaling cascades. They are precise. A growth hormone secretagogue does not flood your body with synthetic growth hormone. It signals your pituitary gland to produce more of your own, in your own natural pulsatile rhythm.
What makes peptides different from SARMs is regulatory legitimacy. SARMs have never received FDA approval for any indication. Peptide drugs have been FDA-approved for decades, across dozens of therapeutic categories, from diabetes management to HIV-associated lipodystrophy to rare mitochondrial disorders.
The peptide drug class encompasses everything from blockbuster GLP-1 receptor agonists prescribed to millions of patients, to emerging compounds still building their evidence base in clinical research. That range is precisely why a guide like this matters. Not all peptides are created equal, and understanding the evidence behind each one is the difference between informed medicine
and guesswork.
One more thing worth noting. The word “peptide” has been co-opted by the skincare industry to mean almost nothing. “Peptide serums” and “peptide-infused moisturizers” have diluted the term into marketing noise. The compounds in this guide are not cosmetic marketing. They are bioactive molecules with characterized mechanisms of action, published clinical data, and, in many cases, FDA approval. The science is real. The evidence is measurable. The field is moving faster than most people realize.
how peptides work in the body
Most peptides exert their effects through receptor binding. A peptide circulates through the bloodstream or acts locally at the site of injection, finds its target receptor on a cell surface, and triggers an intracellular signaling cascade. That cascade might activate enzymes, release second messengers, or alter gene expression in the nucleus. The specificity of this interaction is what makes peptides so interesting therapeutically.
Not all peptides follow this model. BPC-157 acts through multiple mechanisms, including VEGF-dependent and independent nitric oxide production, FAK-paxillin pathway activation, and gene expression modulation, without a single defined receptor. GHK-Cu influences over 4,000 genes primarily through copper transport and gene-expression networks rather than classical receptor binding. The diversity of mechanisms across the peptide class is part of what makes it pharmacologically rich. Some peptides are precise receptor keys. Others operate through broader signaling networks. Both approaches can produce meaningful biological effects.
Half-lifeIs the first thing to understand about any peptide protocol. Native GLP-1, the gut hormone, has a half-life of about 2 minutes. Semaglutide, the engineered analog, lasts approximately 7 days. Native GHRH lasts minutes. CJC-1295 with its albumin-binding technology persists for 6 to 8 days. Half-life determines dosing frequency, onset of action, and the steadiness of the therapeutic effect. |
Bioavailabilityis the second factor. Most peptides cannot survive the digestive system intact. Stomach acid and proteolytic enzymes break the amino acid chains apart before they reach the bloodstream. This is why the vast majority of peptides are administered via subcutaneous injection: a small needle into the fatty tissue just beneath the skin. Some peptides work topically (GHK-Cu in skincare, for example). Oral peptide delivery is an active area of pharmaceutical research, and the landscape shifted meaningfully in 2025 and 2026. Novo Nordisk’s oral semaglutide (Rybelsus) proved the gastrointestinal barrier could be overcome using an absorption enhancer. The January 2026 launch of oral Wegovy extended that breakthrough to obesity treatment. And Johnson & Johnson’s icotrokinra, approved in March 2026, demonstrated that targeted oral peptides can achieve clinical efficacy in autoimmune disease.. |
Routes of administration
|
Context matters more than most people realize.
The same peptide can produce different outcomes depending on the individual’s physiology: age, body composition, training status, sleep quality, caloric state, and concurrent medications all influence how the body responds to a given signal. A growth hormone secretagogue administered to a sleep-deprived, under-recovered individual will not produce the same result as the same compound in someone with optimized sleep architecture and adequate protein intake. Peptides amplify biological signals. They do not replace the foundations those signals depend on.
This is exactly why organizations like the Enhanced Games maintain an 11-member independent medical commission to supervise every peptide protocol their athletes use. The compound is only part of the equation. The clinical context is everything.
